Sen. Grassley’s Proposed Drug Safety Office Would Have Labeling Authority
This article was originally published in The Tan Sheet
Executive Summary
Sen. Charles Grassley (R-Iowa) will propose legislation creating an independent drug safety office at FDA that would have authority to alter drug labeling and possibly suspend direct-to-consumer advertising